Lipella Pharmaceuticals Inc. ( LIPO) - Key Metrics
LIPO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q3 | $0 | -$0.28 | -$518.29 | -$518.29 |
| 2025Q2 | $0 | -$0.31 | -$0.33 | -$0.33 |
| 2025Q1 | $0 | -$1.25 | -$1.36 | -$1.36 |
| 2024Q4 | $0.17 | -$1.38 | -$0.94 | -$0.94 |
| 2024Q3 | $0 | -$1.29 | -$0.58 | -$0.58 |
LIPO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q3 | 0% | -0.54 |
| 2025Q2 | 0% | -0.70 |
| 2025Q1 | 0% | -0.98 |
| 2024Q4 | 0% | -0.56 |
| 2024Q3 | 0% | -5.85 |
LIPO
Price: $0
52 week price:
Earnings Per Share: -2.26 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 2310